CN102793736A - Buccal tablet with removing throat heat and promoting diuresis - Google Patents
Buccal tablet with removing throat heat and promoting diuresis Download PDFInfo
- Publication number
- CN102793736A CN102793736A CN2012102591882A CN201210259188A CN102793736A CN 102793736 A CN102793736 A CN 102793736A CN 2012102591882 A CN2012102591882 A CN 2012102591882A CN 201210259188 A CN201210259188 A CN 201210259188A CN 102793736 A CN102793736 A CN 102793736A
- Authority
- CN
- China
- Prior art keywords
- weight portion
- buccal tablet
- weight
- group
- weight portions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006189 buccal tablet Substances 0.000 title claims abstract description 62
- 229940046011 buccal tablet Drugs 0.000 title claims abstract description 61
- 208000004880 Polyuria Diseases 0.000 title abstract description 22
- 230000035619 diuresis Effects 0.000 title abstract description 19
- 230000001737 promoting effect Effects 0.000 title abstract 3
- 238000002360 preparation method Methods 0.000 claims abstract description 31
- 230000000694 effects Effects 0.000 claims abstract description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 23
- 239000000843 powder Substances 0.000 claims abstract description 17
- 238000010438 heat treatment Methods 0.000 claims abstract description 11
- 238000001035 drying Methods 0.000 claims abstract description 7
- 239000000463 material Substances 0.000 claims abstract description 6
- 239000002994 raw material Substances 0.000 claims abstract description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 26
- 235000013336 milk Nutrition 0.000 claims description 18
- 239000008267 milk Substances 0.000 claims description 18
- 210000004080 milk Anatomy 0.000 claims description 18
- 238000004140 cleaning Methods 0.000 claims description 17
- 239000012567 medical material Substances 0.000 claims description 17
- 241000196324 Embryophyta Species 0.000 claims description 14
- 241000628997 Flos Species 0.000 claims description 14
- 239000003814 drug Substances 0.000 claims description 14
- 230000001882 diuretic effect Effects 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 13
- 239000008187 granular material Substances 0.000 claims description 12
- 239000002934 diuretic Substances 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 10
- 239000013521 mastic Substances 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 8
- 239000002304 perfume Substances 0.000 claims description 8
- 230000028327 secretion Effects 0.000 claims description 8
- 230000004936 stimulating effect Effects 0.000 claims description 8
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 7
- 229920002472 Starch Polymers 0.000 claims description 7
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 7
- 239000013067 intermediate product Substances 0.000 claims description 7
- 239000011734 sodium Substances 0.000 claims description 7
- 229910052708 sodium Inorganic materials 0.000 claims description 7
- 239000008107 starch Substances 0.000 claims description 7
- 235000019698 starch Nutrition 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- -1 hydroxyl isomaltulose Chemical compound 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 5
- 235000008504 concentrate Nutrition 0.000 claims description 5
- 230000006837 decompression Effects 0.000 claims description 5
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- NOOLISFMXDJSKH-UHFFFAOYSA-N p-menthan-3-ol Chemical compound CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 5
- 238000005303 weighing Methods 0.000 claims description 5
- 108010016626 Dipeptides Proteins 0.000 claims description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 4
- 229930006000 Sucrose Natural products 0.000 claims description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 4
- 125000003118 aryl group Chemical group 0.000 claims description 4
- 230000015572 biosynthetic process Effects 0.000 claims description 4
- 229930182478 glucoside Natural products 0.000 claims description 4
- 150000008131 glucosides Chemical class 0.000 claims description 4
- JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 claims description 4
- 229960000511 lactulose Drugs 0.000 claims description 4
- PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 claims description 4
- 239000000314 lubricant Substances 0.000 claims description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 4
- 150000002772 monosaccharides Chemical class 0.000 claims description 4
- 239000005720 sucrose Substances 0.000 claims description 4
- 150000003445 sucroses Chemical class 0.000 claims description 4
- 230000008961 swelling Effects 0.000 claims description 4
- 238000003786 synthesis reaction Methods 0.000 claims description 4
- 108090000623 proteins and genes Proteins 0.000 claims description 3
- 102000004169 proteins and genes Human genes 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- 239000003765 sweetening agent Substances 0.000 claims description 3
- NUFKRGBSZPCGQB-FLBSXDLDSA-N (3s)-3-amino-4-oxo-4-[[(2r)-1-oxo-1-[(2,2,4,4-tetramethylthietan-3-yl)amino]propan-2-yl]amino]butanoic acid;pentahydrate Chemical compound O.O.O.O.O.OC(=O)C[C@H](N)C(=O)N[C@H](C)C(=O)NC1C(C)(C)SC1(C)C.OC(=O)C[C@H](N)C(=O)N[C@H](C)C(=O)NC1C(C)(C)SC1(C)C NUFKRGBSZPCGQB-FLBSXDLDSA-N 0.000 claims description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 2
- PVXPPJIGRGXGCY-TZLCEDOOSA-N 6-O-alpha-D-glucopyranosyl-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)C(O)(CO)O1 PVXPPJIGRGXGCY-TZLCEDOOSA-N 0.000 claims description 2
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 claims description 2
- 244000298697 Actinidia deliciosa Species 0.000 claims description 2
- 235000009436 Actinidia deliciosa Nutrition 0.000 claims description 2
- 239000004377 Alitame Substances 0.000 claims description 2
- 108010011485 Aspartame Proteins 0.000 claims description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
- 108010001394 Disaccharidases Proteins 0.000 claims description 2
- 239000004386 Erythritol Substances 0.000 claims description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 2
- 229930091371 Fructose Natural products 0.000 claims description 2
- 239000005715 Fructose Substances 0.000 claims description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 2
- 244000068988 Glycine max Species 0.000 claims description 2
- 235000010469 Glycine max Nutrition 0.000 claims description 2
- 239000004378 Glycyrrhizin Substances 0.000 claims description 2
- 229920001908 Hydrogenated starch hydrolysate Polymers 0.000 claims description 2
- XINCECQTMHSORG-UHFFFAOYSA-N Isoamyl isovalerate Chemical compound CC(C)CCOC(=O)CC(C)C XINCECQTMHSORG-UHFFFAOYSA-N 0.000 claims description 2
- AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 2
- 229930195725 Mannitol Natural products 0.000 claims description 2
- 240000008790 Musa x paradisiaca Species 0.000 claims description 2
- 235000018290 Musa x paradisiaca Nutrition 0.000 claims description 2
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 claims description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 2
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 2
- 239000004376 Sucralose Substances 0.000 claims description 2
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 claims description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 2
- 235000010358 acesulfame potassium Nutrition 0.000 claims description 2
- 239000000619 acesulfame-K Substances 0.000 claims description 2
- 102000011759 adducin Human genes 0.000 claims description 2
- 108010076723 adducin Proteins 0.000 claims description 2
- 235000019409 alitame Nutrition 0.000 claims description 2
- 108010009985 alitame Proteins 0.000 claims description 2
- 239000000605 aspartame Substances 0.000 claims description 2
- 235000010357 aspartame Nutrition 0.000 claims description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 2
- 229960003438 aspartame Drugs 0.000 claims description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 2
- 239000002131 composite material Substances 0.000 claims description 2
- 229940109275 cyclamate Drugs 0.000 claims description 2
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 claims description 2
- PXLWOFBAEVGBOA-UHFFFAOYSA-N dihydrochalcone Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=CC(C(=O)CC(O)C=2C=CC(O)=CC=2)=C1O PXLWOFBAEVGBOA-UHFFFAOYSA-N 0.000 claims description 2
- QGGZBXOADPVUPN-UHFFFAOYSA-N dihydrochalcone Chemical compound C=1C=CC=CC=1C(=O)CCC1=CC=CC=C1 QGGZBXOADPVUPN-UHFFFAOYSA-N 0.000 claims description 2
- 235000019414 erythritol Nutrition 0.000 claims description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 2
- 229940009714 erythritol Drugs 0.000 claims description 2
- 235000003599 food sweetener Nutrition 0.000 claims description 2
- 235000021433 fructose syrup Nutrition 0.000 claims description 2
- 229930182470 glycoside Natural products 0.000 claims description 2
- 150000002338 glycosides Chemical class 0.000 claims description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 claims description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 claims description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 claims description 2
- 235000019410 glycyrrhizin Nutrition 0.000 claims description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 2
- 238000005469 granulation Methods 0.000 claims description 2
- 230000003179 granulation Effects 0.000 claims description 2
- 239000008172 hydrogenated vegetable oil Substances 0.000 claims description 2
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 claims description 2
- 239000008101 lactose Substances 0.000 claims description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 claims description 2
- 235000019359 magnesium stearate Nutrition 0.000 claims description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 2
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 2
- 239000000594 mannitol Substances 0.000 claims description 2
- 235000010355 mannitol Nutrition 0.000 claims description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 2
- 229920001542 oligosaccharide Polymers 0.000 claims description 2
- 150000002482 oligosaccharides Polymers 0.000 claims description 2
- 239000007968 orange flavor Substances 0.000 claims description 2
- 229920001223 polyethylene glycol Polymers 0.000 claims description 2
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 claims description 2
- 239000000741 silica gel Substances 0.000 claims description 2
- 229910002027 silica gel Inorganic materials 0.000 claims description 2
- 239000000600 sorbitol Substances 0.000 claims description 2
- 235000010356 sorbitol Nutrition 0.000 claims description 2
- 238000001694 spray drying Methods 0.000 claims description 2
- 229940013618 stevioside Drugs 0.000 claims description 2
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 2
- 235000019202 steviosides Nutrition 0.000 claims description 2
- 235000019408 sucralose Nutrition 0.000 claims description 2
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical group O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 2
- 239000000811 xylitol Substances 0.000 claims description 2
- 235000010447 xylitol Nutrition 0.000 claims description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 2
- 229960002675 xylitol Drugs 0.000 claims description 2
- 229960002160 maltose Drugs 0.000 claims 1
- 229960001855 mannitol Drugs 0.000 claims 1
- 229960002920 sorbitol Drugs 0.000 claims 1
- 206010030113 Oedema Diseases 0.000 abstract description 26
- 240000000249 Morus alba Species 0.000 abstract description 3
- 235000008708 Morus alba Nutrition 0.000 abstract description 3
- 244000274050 Platycodon grandiflorum Species 0.000 abstract description 2
- 238000005453 pelletization Methods 0.000 abstract description 2
- 235000007516 Chrysanthemum Nutrition 0.000 abstract 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract 1
- 235000006753 Platycodon grandiflorum Nutrition 0.000 abstract 1
- 241001106462 Ulmus Species 0.000 abstract 1
- 230000006651 lactation Effects 0.000 abstract 1
- 235000020238 sunflower seed Nutrition 0.000 abstract 1
- 210000003800 pharynx Anatomy 0.000 description 20
- 241000699670 Mus sp. Species 0.000 description 11
- 241000700159 Rattus Species 0.000 description 10
- 208000024891 symptom Diseases 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 7
- 210000002700 urine Anatomy 0.000 description 6
- 208000019395 Lactation disease Diseases 0.000 description 5
- 206010042576 Suppressed lactation Diseases 0.000 description 5
- 210000000481 breast Anatomy 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 230000036541 health Effects 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 230000035807 sensation Effects 0.000 description 4
- 235000019615 sensations Nutrition 0.000 description 4
- 241000186016 Bifidobacterium bifidum Species 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 230000037006 agalactosis Effects 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000000378 dietary effect Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 210000003141 lower extremity Anatomy 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 2
- 206010013911 Dysgeusia Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 208000017574 dry cough Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 210000000867 larynx Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 2
- 238000002562 urinalysis Methods 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000006008 Brassica napus var napus Nutrition 0.000 description 1
- 241000208671 Campanulaceae Species 0.000 description 1
- 241000189115 Catananche Species 0.000 description 1
- 241001518926 Cladrastis Species 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 241000252233 Cyprinus carpio Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 206010015993 Eyelid oedema Diseases 0.000 description 1
- 206010016029 Face oedema Diseases 0.000 description 1
- 240000004859 Gamochaeta purpurea Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 241000219071 Malvaceae Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- 241000186359 Mycobacterium Species 0.000 description 1
- 208000024818 Nipple disease Diseases 0.000 description 1
- 206010030124 Oedema peripheral Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 235000006751 Platycodon Nutrition 0.000 description 1
- 208000002787 Pregnancy Complications Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000531795 Salmonella enterica subsp. enterica serovar Paratyphi A Species 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000193990 Streptococcus sp. 'group B' Species 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 241000218220 Ulmaceae Species 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 210000002445 nipple Anatomy 0.000 description 1
- 235000013615 non-nutritive sweetener Nutrition 0.000 description 1
- 229940096978 oral tablet Drugs 0.000 description 1
- 239000007935 oral tablet Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 229930189914 platycodon Natural products 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001603 reducing effect Effects 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 239000007779 soft material Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 235000021092 sugar substitutes Nutrition 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 235000007063 yellowwood Nutrition 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention relates to a buccal tablet with removing throat heat and promoting diuresis. The buccal tablet is prepared from the following 5 raw materials in parts by weight: 100 to 400 parts of elm root bark, 100 to 400 parts of platycodon grandiflorum, 100 to 400 parts of mulberry leaves, 100 to 400 parts of chrysanthemum, and 100 to 400 parts of sunflower seeds. A preparation process of the buccal tablet comprises the following steps: 1) immersing the five raw materials; 2) heating and extracting with water; 3) concentrating the water extract to prepare an extract; 4) drying and crushing the extract to obtain powder; and 5) mixing the powder and auxiliary materials, pelletizing, drying, granulating, and tabletting. The buccal tablet has remarkable effects of removing throat heat and promoting diuresis, and can be used for eliminating the internal dropsy and postpartum edema and unsmooth lactation of a parturient.
Description
Technical field
The present invention relates to a kind of oral tablet, relate in particular to a kind of buccal tablet, this buccal tablet has the effect of moistening and cleaning throat diuretic.
Background technology
Buccal tablet because of its good mouthfeel and easily instructions of taking receive the welcome of extensive patients.It has the following advantages: 1. act directly on pharyngeal.Have effects such as antibacterial, antibacterial, antiinflammatory, detumescence, desaturation thick secretions, convergence, stimulating mucosal secretion.2. because containing slowly, it is pharyngeal that medicine can be rested on the long period, continues the performance drug effect.3. for alleviating uncomfortable sensation such as dry pharynx, pharyngalgia instant effect.Simultaneously, because the buccal tablet mouthfeel is good, taking convenience receives broad masses' welcome deeply.
But buccal tablet before often is confined to the treatment of pharyngeal discomfort, also can get into blood circulation because oral mucosa absorbs the back medicine, so utilize the buccal tablet mouthfeel good, the advantage of taking convenience also can reach other health care purpose.And this respect research is less in the actual life, such as the preparation of the buccal tablet that does not relate to the moistening and cleaning throat diuretic.
All the time, edema is often perplexing all kinds of crowds, and edema is divided into following several types:
Idiopathic edema: some women of 20 to 40 years old, after getting up morning, the normal had slight edema of eyelid and face, lower limb have pitting edema or tight sense, along with activity, alleviate gradually or disappear.
Reactive edema: particularly work in hot environment or health are more fat does not like movable person again for some people, receive the influence of high ambient temperature, the skin heart diffusion; The body fluid infiltration also accumulates in subcutaneous tissue, and the hands of being everlasting, foot etc. locate to take place edema, after summer; Then disappear voluntarily, but every Xia Bifa, repeatedly for many years.
Position property edema: stand for a long time, walk, squat down or seat, can be because of the lower limb obstruction of blood return, alluvial causes edema, and a period of time behind the change position, edema can alleviate voluntarily, disappears.
Premenstruum edema: some health female is in menstrual onset the last week or two weeks; Eyelid, the back of the hand, ankle even the slight edema of two lower limb appear; And symptom such as agitation, insomnia, tired, headache, during menstrual onset, edema and other symptoms can disappear gradually.
Medicine property edema: as using medicines such as adrenocortical hormone, testosterone, androgen, insulin, thiourea, Radix Glycyrrhizae, can cause face, hands, foot edema to occur, edema can disappear gradually after the drug withdrawal.
Puerperal edema: puerperal especially after the cesarean in order to diminish inflammation, prevention infection is infused in body in a large number, and moisture period of retention is in vivo easily just during this period of time caused puerperal edema easily, and difficult the elimination.
Edema has caused influence to the personage that much likes to be beautiful, and also very unfavorable to the operation of physical function of self.The past people perhaps let matters drift, and perhaps adopt the way of dietetic therapy, but dietetic therapy are not suitable for present allegro life sometimes.The needs that also do not have at present a kind ofly conveniently to take, effective, the buccal tablet with the effect of moistening and cleaning throat diuretic that mouthfeel is good satisfy everybody.
Summary of the invention
The problem that the present invention need solve provides and a kind ofly conveniently takes, the buccal tablet with the effect of moistening and cleaning throat diuretic effective, that mouthfeel is good satisfies everybody needs for detumescencing diuresis.
Technical problem to be solved by this invention realizes through following technical scheme:
A kind of buccal tablet with the effect of moistening and cleaning throat diuretic, this buccal tablet is made by following raw material:
Radix et Cortex ulmi pumilae 100-400 weight portion Radix Platycodonis 100-400 weight portion
Folium Mori 100-400 weight portion Flos Chrysanthemi 100-400 weight portion certain herbaceous plants with big flowers 100-400 weight portion
Wherein, Radix et Cortex ulmi pumilae is the root bark of Ulmaceae plant elm, and sweet in the mouth, property are put down.Loosening bowel to relieve constipation is arranged, inducing diuresis to remove edema, the effect of heat-clearing and toxic substances removing.Be applicable to abdominal distention, constipation, edema and dysuria.
Radix Platycodonis is the dried roots of campanulaceae Platycodon grandiflouorum, bitter in the mouth, suffering, and slightly warm in nature is gone into lung meridian.The ability expelling phlegm for arresting cough, and lung qi dispersing, evacuation of pus effect are arranged.Its young stem and leaf and root all can supply cooked food, abound with in area, China northeast, and be the speciality of Korean nationality.
Folium Mori are dried leaves of moraceae plants Mulberry, have another name called tame Mulberry, Jing Sang, Fructus Mori tree, yellow wood etc., and national most of areas has production more, has effects such as blood pressure lowering, blood fat reducing, antiinflammatory, diuresis, can dispelling wind and heat pathogens, and clearing away lung-heat and moistening for dryness, liver heat removing and eyesight improving.
Flos Chrysanthemi, perennial catananche, its petal is ligule or tubular.Diffusing wind heat clearing away, suppressing the hyperactive liver makes eye bright.Be used for anemopyretic cold, it is dizzy to have a headache, conjunctival congestion and swelling pain, and eyes is dim-sighted, and calmness, refrigeration function are arranged.Staphylococcus aureus, group B streptococcus, dysentery bacterium, Bacillus typhi, Salmonella paratyphi, escherichia coli, bacillus pyocyaneus, mycobacterium hominis and influenza virus all there is inhibitory action.
Certain herbaceous plants with big flowers has another name called Semen Abutili, certain herbaceous plants with big flowers colza.Be the mature seed of Malvaceae annual herb plant Semen Abutili, all produce all over China.Gather during seed maturity summer and autumn, dries, and gives birth to usefulness, smashs to pieces and be used as medicine.These article are sweet cold sliding sharp, can relieving stranguria by diuresis, again can stimulating milk secretion, intestine moistening, and difficulty in urination and defecation person is all suitable.
By the buccal tablet that above medical material is processed, prescription is balanced, wherein, Radix et Cortex ulmi pumilae, Folium Mori, all ability diuresis of certain herbaceous plants with big flowers, intestine moistening, and Radix Platycodonis, Flos Chrysanthemi, Folium Mori can loose wind heat clearing away, throat-benefiting have antiinflammatory, bacteriostatic effect concurrently.Thus can moistening and cleaning throat, again can diuretic.Simultaneously, this side also is applicable to women's puerperal edema, the stimulating milk secretion impassable patient.
This buccal tablet is conveniently taken, mouthfeel is good, effect is good, and the puzzlement that can solve the suffered edema of most of people does not freely have good effect for women's puerperal edema, stimulating milk secretion simultaneously, makes that the women can be popular Gospel in fast quick-recovery figure in puerperal.
The specific embodiment
The present invention is preferred, aforesaid buccal tablet with the effect of moistening and cleaning throat diuretic, and this buccal tablet is made by following raw material:
Radix et Cortex ulmi pumilae 100 weight portion Radix Platycodoniss 100 weight portion Folium Mori 100 weight portions
Flos Chrysanthemi 100 weight portion certain herbaceous plants with big flowers 100 weight portions
A kind of method for preparing with buccal tablet of moistening and cleaning throat diuretic effect can may further comprise the steps:
1) to Radix et Cortex ulmi pumilae 100-400 weight portion, Radix Platycodonis 100-400 weight portion, Folium Mori 100-400 weight portion, Flos Chrysanthemi 100-400 weight portion, in the certain herbaceous plants with big flowers 100-400 weight portion, the water logging that adds 5-20 times of volume of medical material gross weight was steeped 30-60 minute;
2) heating steps 1) in medical material and water, make temperature remain on 80-100 ℃, water is carried 0.5-3 hour, filters; Filtering residue uses the water of 5-20 times of volume of medical material gross weight respectively, and heating makes temperature remain on 80-100 ℃, repeats water and carries 1-3 time, each 0.5-3 hour, filters merging filtrate;
3) will filtrate and concentrate, preparation proportion is the mastic between the 1.2-1.8 g/cm3;
4) with after mastic vacuum decompression crushed after being dried or the spray drying, cross the 60-120 mesh sieve, make the medicated powder powder;
5) get the powder 50-100 weight portion that step 4) makes, carboxymethyl starch sodium 0.1-10 weight portion, sweeting agent 50-300 weight portion, behind the mix homogeneously, adding concentration is the ethanol 5-100 weight portion granulation between the 50-95%, drying, granulate.
6) in the intermediate products behind granulate, behind adding aromatic 0.05-10 weight portion and lubricant 3 weight portions, tabletting promptly gets.
Wherein sweeting agent is selected from one or more in the group of being made up of functional monosaccharide, functional oligose, multi-sugar alcohol, glucosides, dipeptide, protein-based, sucrose derivative, artificial synthesis edulcorant and composite sweetener; Aromatic is selected from natural perfume material and/or artificial perfume, and lubricant is selected from one or more in the group of being made up of magnesium stearate, micropowder silica gel, Pulvis Talci, hydrogenated vegetable oil, polyethylene glycols and the pure magnesium sulfate of moon extension.
In the group that the preferred free high fructose syrup of functional monosaccharide, fructose and L-sugar etc. are formed one or more; In the group that the preferred free isomaltulose of functional oligose, lactulose, Raffinose, soybean oligo saccharide, oligofructose, oligomeric lactulose, oligomeric lactose and oligomeric isomaltose etc. are formed one or more; In the group that the preferred free erythritol of multi-sugar alcohol, xylitol, Sorbitol, mannitol, maltose alcohol, the pure and mild hydrogenated starch hydrolysate of dextrinose etc. are formed one or more; In the group that the preferred free stevioside of glucosides, Flos Chrysanthemi disaccharidase glycosides, dihydrochalcone and glycyrrhizin etc. are formed one or more; Preferred aspartame of dipeptide and/or alitame; Protein-based preferably one or more in the group that Suo Matian, Mo Nailin and kiwi fruit etc. are formed; Sucrose derivative is preferably from sucralose etc.; In the group that the preferred free glucide of artificial synthesis edulcorant, cyclamate and acesulfame-K etc. are formed one or more; In the group that the preferred free Fructus Citri Limoniae of natural perfume material, Fructus Foeniculi, Oleum menthae and Oleum Eucalypti etc. are formed one or more; In the group that the preferred free apple essence of artificial perfume, flavoring orange essence, flavoring banana essence, Mentholum and orange flavor etc. are formed one or more.
A kind of method for preparing with buccal tablet of moistening and cleaning throat diuretic effect, this step specifically can be:
1) to Radix et Cortex ulmi pumilae 100 weight portions, Radix Platycodonis 100 weight portions, Folium Mori 100 weight portions, Flos Chrysanthemi 100 weight portions, the water logging that adds 12 times of volumes of medical material gross weight in certain herbaceous plants with big flowers 100 weight portions was steeped 30 minutes;
2) heating steps 1) in medical material and water, boiled 2 hours, filter, filtering residue adds the water heating of 10 times of volumes of medical material gross weight once more, boils 2 hours, filters merging filtrate;
3) will filtrate and concentrate, preparation proportion is the mastic of 1.5g/cm3;
4) with mastic vacuum decompression crushed after being dried, cross 120 mesh sieves, make the medicated powder powder;
5) get powder 100 weight portions that step 4) makes, carboxymethyl starch sodium 1 weight portion, sucrose 50 weight portions, hydroxyl isomaltulose 100 weight portions behind the mix homogeneously, add 95% ethanol, 15 weight portions and granulate drying, granulate.
6) take by weighing Mentholum 3 weight portions and be dissolved in the intermediate products that spray in the small amount of ethanol behind the granulate, after other added Pulvis Talci 3 weight portions, tabletting promptly got.
The tradition buccal tablet is applicable to usually to be sucked, because tablet hardness is big, disintegrate is slow under one's belt, the drug absorption weak effect when directly swallowing.And used carboxymethyl starch sodium in the preparation process of buccal tablet of the present invention; Carboxymethyl starch sodium is a disintegrating agent commonly used in the common swallow tablet, and the inventor is through exploring, and makes the method for preparing of this buccal tablet; The big characteristics of buccal tablet hardness had both been satisfied; The also interior disintegrate of effective time under one's belt can directly be swallowed so this buccal tablet both can have been sucked also simultaneously, did not influence the drug absorption effect; Used hydroxyl isomaltulose; It has the pure taste as sucrose; Do not have bad aftertaste and abnormal flavour, can and cover the latter's bad aftertaste and abnormal flavour, agent of low hygroscopicity, high stability with intense sweetener generation synergistic function; Low-yield, non-dental caries property etc. is so it is a kind of perfect sugar substitute.Its suitable diabetic is edible simultaneously, can not cause that blood glucose and insulin rise.And hydroxyl isomaltulose is a kind of good bacillus bifidus MF; Though hydroxyl isomaltulose can not be utilized by the enzyme of human body and most microorganisms system; But can be by the utilization that bacillus bifidus decomposes in the human body intestinal canal; Promote the growth and breeding of bacillus bifidus, keep the microecological balance of intestinal, help the health of human body.
Use the buccal tablet of above-mentioned steps preparation, can preparation promote the puerpera to subside a swelling puerperal and the medicine of stimulating milk secretion in use.
The puerpera especially after the cesarean through the puerpera Yi Fasheng edema of the body of transfusion, be difficult for eliminating.And in recent years, the patient of women's puerperal hypogalactia is increasing, and common dietetic therapy is drunk into a large amount of decoction and also can be increased the weight of edema, is difficult to satisfy the personage's that likes to be beautiful needs.Buccal tablet of the present invention contains diuretic and following composition of milk, and as oral medicine, need not cook or decoct, and can easily solve the difficult problem that need subside a swelling simultaneously with stimulating milk secretion.
Further describe the present invention below in conjunction with specific embodiment, advantage of the present invention and characteristics will be more clear along with description.But these embodiment only are exemplary, scope of the present invention are not constituted any restriction.It will be understood by those skilled in the art that and down can make amendment with form or replace without departing from the spirit and scope of the present invention, but these modifications and replacing all fall in protection scope of the present invention the details of technical scheme of the present invention.
1 one kinds of buccal tablets with moistening and cleaning throat diuresis of embodiment are made by following five kinds of medical materials:
Radix et Cortex ulmi pumilae 100 weight portion Radix Platycodoniss 100 weight portion Folium Mori 100 weight portions
Flos Chrysanthemi 100 weight portion certain herbaceous plants with big flowers 100 weight portions
Embodiment 2 is according to the concrete method for preparing of embodiment 1 described buccal tablet:
1) to Radix et Cortex ulmi pumilae 100 weight portions, Radix Platycodonis 100 weight portions, Folium Mori 100 weight portions, Flos Chrysanthemi 100 weight portions, the water logging that adds 12 times of volumes of medical material gross weight in certain herbaceous plants with big flowers 100 weight portions was steeped 30 minutes;
2) heating steps 1) in medical material and water, boiled 2 hours, filter, filtering residue adds the water heating of 10 times of volumes of medical material gross weight once more, boils 2 hours, filters merging filtrate;
3) will filtrate and concentrate, preparation proportion is the mastic of 1.5 g/cm3;
4) with mastic vacuum decompression crushed after being dried, cross 120 mesh sieves, make the medicated powder powder;
5) get powder 100 weight portions that step 4) makes, carboxymethyl starch sodium 1 weight portion, sucrose 50 weight portions, hydroxyl isomaltulose 100 weight portions, mix homogeneously is crossed 100 mesh sieves.
6) ethanol 15 weight portions of adding 95% in the intermediate products that step 5) obtains, the preparation soft material uses granulator to granulate, and crosses 16 mesh sieves.Intermediate products after granulating are put into baking oven under 45 ℃, carried out drying 2 hours, use pelletizing machine to carry out granulate then, cross 18 mesh sieves.
7) take by weighing Mentholum 3 weight portions and use the small amount of ethanol dissolving to spray in the intermediate products that step 6) obtains, add Pulvis Talci 3 weight portions, mix homogeneously, tabletting promptly gets, and sheet focuses between the 0.8-0.85g.
The investigation of the moistening and cleaning throat effect of the buccal tablet of preparation among embodiment 3 embodiment 2
1 method
1.1 study subject: select the age between 18 to 65 years old, the chronic pharyngitis patient of main organs illness such as no severe cardiac, liver, kidney is a study subject.
1.2 instructions of taking: 3 times on the 1st, 1 time 2 (buccal) taken 7 days
2 observation index
The inquiry medical history, observe cardinal symptom: pharyngalgia, itching throat, dry pharynx, dry cough and foreign body sensation, investigate the variation of pharyngeal sensation before and after taking and the improvement situation of cardinal symptom.
3 effect criterion
New Chinese medicine clinical research guideline with reference to the Ministry of Public Health promulgation is formulated
3.1 produce effects: symptom obviously alleviates or disappears
3.2 effectively: sx
3.3 it is invalid: the symptom no change
4 results
4.1 physical data: observe 50 routine experimenters altogether, male's 20 examples wherein, women's 30 examples, minimum 18 years old of age, maximum 65 years old, average 40 ± 5 years old.The course of disease is the shortest 1 year, and is the longest 26 years, average 11 ± 6 years.
4.2 the effect of cleaning throat and moistening larynx
The effect of table 1 cleaning throat and moistening larynx
4.3 doing well,improving situation
Table 2 doing well,improving situation
| Symptom | The example number | Produce effects | Effectively | Invalid | Total effective rate (%) |
| Pharyngalgia | 31 | 7 | 18 | 6 | 80.6 |
| Itching throat | 42 | 12 | 23 | 7 | 83.3 |
| Dry pharynx | 46 | 4 | 27 | 15 | 67.4 |
| Dry cough | 38 | 4 | 21 | 13 | 65.8 |
| Foreign body sensation | 43 | 5 | 22 | 16 | 62.8 |
5 conclusions
The buccal tablet of preparation has the effect of moistening and cleaning throat among the embodiment 2.
The buccal tablet of preparation is for the investigation of the diuretic effect of rat and mice among embodiment 4 embodiment 2
1 experiment material
1.1 experiment medicine
The buccal tablet of preparation among the embodiment 2,36/box of SANJIN PIAN (Sanjin Pharmaceutical Co., Ltd., Guilin provides).
1.2 animal and instrument
Cleaning Kunming mouse 18-22g, SD rat 150-200g provides by Shenyang Chinese Medical Sciences University Experimental Animal Center.
2 experimental techniques
2.1 bell jar process
Select 50 of the rats of body weight 150-200g for use, each is half the for male and female, is divided into 5 groups, 10 every group, is respectively buccal tablet high dose group, middle dose groups, the low dose group of preparation among blank group, positive controls, the embodiment 2.Face with before being mixed with suspension, successive administration 7 days is in advance bell jar endoadaptation 2 days; Water 14h is can't help in fasting before the experiment; When beginning experiment gently depressed abdomen, drains surplus urine, and immediately rat put in people's bell jar behind the last gastric infusion; 1 of every bell jar collects 1,2,3 respectively, 4h urine and do urinalysis.
2.2 mice filter paper weight method
Select 50 of the mices of body weight 18-22g for use, each is half the for male and female, is divided into 5 groups, is respectively buccal tablet high dose group, middle dose groups, the low dose group of preparation among blank group, positive controls, the embodiment 2.Face with before being mixed with suspension; Every group 10, successive administration 7 days, fasting can't help water 14 hours before the experiment; Gently depress abdomen during the experiment beginning; Drain surplus urine, and immediately per 2 of mice is placed respectively in 1 glass bell jar behind the last gastric infusion, the gain in weight of the filter paper of weighing immediately after at every turn urinating with analytical balance weight method record.Observed 4 hours continuously, remove the mice faecal pellet on the filter paper when weighing.
3 experimental results
3.1 the buccal tablet of preparation is to the diuresis of rat among the embodiment 2
Buccal tablet high dose group, middle dose groups, the low dose group of preparation all can obviously increase the rat urine amount among the embodiment 2, with the blank group relatively, difference has significance meaning (P < 0.05).Compare nonsignificance (P>0.05) with positive controls.The urinalysis result shows that we do not change the urine composition, see table 3, table 4.
The buccal tablet of preparation is to the experimental result of rat diuresis among table 3 embodiment 2
Annotate: compare * P < 0.05 with the blank group
The buccal tablet of preparation is to the experimental result of rat diuresis among table 4 embodiment 2
| Group | Dosage (g/kg) | Tatol emiction quantity |
| Blank control group | - | 4.29±1.37 |
| Positive group | 0.282 | 7.89±1.73 |
| High dose group | 1.4 | 7.31±0.66 |
| Middle dose groups | 0.7 | 7.51±1.64 |
| Low dose group | 0.35 | 6.99±1.44 |
Annotate: comparing with SANJIN PIAN does not have significant difference
3.2 the buccal tablet of preparation is to the diuresis of mice among the embodiment 2
The buccal tablet high dose group of preparation among the embodiment 2, middle dose groups, low dose group can obviously increase the mice voided volume, and the urine amount is compared difference significance (P < 0.05) with the blank group, relatively do not have significant difference with positive controls, sees table 5, table 6.
The buccal tablet of preparation is to the experimental result of mice diuresis among table 5 embodiment 2
| Group | Dosage (g/kg) | Tatol emiction quantity (g) |
| Blank control group | - | 0.14±0.13 |
| Positive group | 0.47 | 0.24±0.12* |
| High dose group | 2.8 | 0.22±0.15* |
| Middle dose groups | 1.4 | 0.21±0.12* |
| Low dose group | 0.7 | 0.19±0.11* |
Annotate: compare * P < 0.05 with the blank group
The buccal tablet of preparation is to the experimental result of mice diuresis among table 6 embodiment 2
| Group | Dosage (g/kg) | Tatol emiction quantity |
| Blank control group | - | 0.14±0.13 |
| Positive group | 0.47 | 0.24±0.12 |
| High dose group | 2.8 | 0.22±0.15 |
| Middle dose groups | 1.4 | 0.21±0.12 |
| Low dose group | 0.7 | 0.19±0.11 |
Annotate: comparing with SANJIN PIAN does not have notable difference
4 conclusions
The buccal tablet of preparation shows rat and mice diuresis result of the test among the embodiment 2; Tangible diuresis was all arranged after administration in 1,2,3,4 hour; Its diuresis was reaching the peak in 2-3 hour. in the medication 4 hours among SANJIN PIAN and the embodiment 2 buccal tablet of preparation the voided volume of rat and mice all obviously is superior to normal saline. but the buccal tablet for preparing among SANJIN PIAN and the embodiment 2 urinated and do not have significant difference between the total amount in 4 hours, thereby the buccal tablet for preparing in the illustrative embodiment 2 has the diuresis of similar SANJIN PIAN.
The buccal tablet of preparation is applied to promote puerpera Ruzhong under puerperal among embodiment 5 embodiment 2
1 method
1.1 study subject: all cases are primiparity, single tire, and vagina production or dig the palace and produce agalactia or the very few patient of breast in 3 days puerperal is got rid of with serious pregnancy complication and complication and the patient that taken the medicine that influences galactopoiesis.
1.2 diagnostic criteria:
Agalactia: the conscious breast of puerpera in 2-3 days puerperal does not expand, and no milk is discharged, and the inspection breast is soft, does not still have milk during extruding and discharges.
Hypogalactia: the conscious breast of puerpera in 2-3 days puerperal does not expand not bitterly, and milk is rare, and neonate needs frequently to suck for a long time, continues to surpass 20min, and at interval less than 1 hour, breast is full not obvious during inspection, and a small amount of milk is arranged during extruding.
Eliminating is obstructed because of the human milk silt that crater nipple and cracked nipple cause, dysilthia.
The buccal tablet 3 times on the 1st of preparation among 1.3 instructions of taking: the embodiment 2,1 time 4, Fructus Chaenomelis gold carp soup is drunk in daily cooperation.
2 curative effect determinate standards: intend certainly
2.1 produce effects: the milk amount can satisfy the baby has enough, and does not need with milk.
2.2 effectively: the milk amount can satisfy consumption by infants basically, the interpolation milk of partly still needing, but be no more than 30ml at every turn.
2.3 invalid: the milk amount can not satisfy consumption by infants, relies on artificial feeding basically, and is with milk at every turn>30ml.
3 results
3.1 physical data: puerperal hypogalactia women 60 examples, wherein age average (29 ± 3) year; Pregnant Zhou Pingjun (38.2 ± 1.4) week; Average (162.1 ± 5.1) cm of height; Weight average (71.2 ± 9.8) kg.
3.2 doing well,improving situation
Table 6 doing well,improving situation
| Symptom | The example number | Produce effects | Effectively | Invalid | Total effective rate (%) |
| Agalactia | 12 | 2 | 6 | 4 | 66.7 |
| Hypogalactia | 48 | 7 | 34 | 7 | 85.4 |
3.3 conclusion
The buccal tablet of preparation has the effect that promotes puerpera's stimulating milk secretion in puerperal among the embodiment 2, is applicable to the puerperal hypogalactia patient.
Claims (7)
1. buccal tablet with the effect of moistening and cleaning throat diuretic is characterized in that this buccal tablet is made by following raw material:
Radix et Cortex ulmi pumilae 100-400 weight portion Radix Platycodonis 100-400 weight portion
Folium Mori 100-400 weight portion Flos Chrysanthemi 100-400 weight portion certain herbaceous plants with big flowers 100-400 weight portion.
2. buccal tablet according to claim 1 is characterized in that this buccal tablet is made by following raw material:
Radix et Cortex ulmi pumilae 100 weight portion Radix Platycodoniss 100 weight portion Folium Mori 100 weight portions
Flos Chrysanthemi 100 weight portion certain herbaceous plants with big flowers 100 weight portions.
3. the method for preparing of the described buccal tablet of claim 1 comprises following steps:
1) to Radix et Cortex ulmi pumilae 100-400 weight portion, Radix Platycodonis 100-400 weight portion, Folium Mori 100-400 weight portion, Flos Chrysanthemi 100-400 weight portion, the water logging that adds 5-20 times of volume of medical material gross weight in the certain herbaceous plants with big flowers 100-400 weight portion was steeped 30-60 minute;
2) heating steps 1) in medical material and water, make temperature remain on 80-100 ℃, water is carried 0.5-3 hour, filters; Filtering residue uses the water of 5-20 times of volume of medical material gross weight respectively, and heating makes temperature remain on 80-100 ℃, repeats water and carries 1-3 time, each 0.5-3 hour, filters merging filtrate;
3) will filtrate and concentrate, preparation proportion is the mastic between the 1.2-1.8 g/cm3;
4) with after mastic vacuum decompression crushed after being dried or the spray drying, cross the 60-120 mesh sieve, make the medicated powder powder;
5) get the powder 50-100 weight portion that step 4) makes, carboxymethyl starch sodium 0.1-10 weight portion, sweeting agent 50-300 weight portion, behind the mix homogeneously, adding concentration is the ethanol 5-100 weight portion granulation between the 50-95%, drying, granulate;
6) in the intermediate products behind granulate, behind adding aromatic 0.05-10 weight portion and the lubricant 0.5-10 weight portion, tabletting promptly gets.
4. the method for preparing of buccal tablet according to claim 3, wherein sweeting agent is selected from one or more in the group of being made up of functional monosaccharide, functional oligose, multi-sugar alcohol, glucosides, dipeptide, protein-based, sucrose derivative, artificial synthesis edulcorant and composite sweetener; Aromatic is selected from natural perfume material and/or artificial perfume, and lubricant is selected from one or more in the group of being made up of magnesium stearate, micropowder silica gel, Pulvis Talci, hydrogenated vegetable oil, polyethylene glycols and the pure magnesium sulfate of moon extension.
5. the method for preparing of buccal tablet according to claim 4, wherein, functional monosaccharide is selected from one or more in the group of being made up of high fructose syrup, fructose and L-sugar; Functional oligose is selected from one or more in the group of being made up of isomaltulose, lactulose, Raffinose, soybean oligo saccharide, oligofructose, oligomeric lactulose, oligomeric lactose and oligomeric isomaltose; Multi-sugar alcohol is selected from one or more in the group of being made up of erythritol, xylitol, Sorbitol, mannitol, maltose alcohol, the pure and mild hydrogenated starch hydrolysate of dextrinose; Glucosides is selected from one or more in the group of being made up of stevioside, Flos Chrysanthemi disaccharidase glycosides, dihydrochalcone and glycyrrhizin; Dipeptide is selected from by aspartame and/or alitame; Protein-basedly be selected from the group that Suo Matian, Mo Nailin and kiwi fruit form one or more; Sucrose derivative is selected from sucralose; The artificial synthesis edulcorant is selected from one or more in the group of being made up of glucide, cyclamate and acesulfame-K; Natural perfume material is selected from one or more in the group of being made up of Fructus Citri Limoniae, Fructus Foeniculi, Oleum menthae and Oleum Eucalypti; Artificial perfume is selected from one or more in the group of being made up of apple essence, flavoring orange essence, flavoring banana essence, Mentholum and orange flavor.
6. according to the method for preparing of each described buccal tablet among the claim 3-5, wherein:
1) to Radix et Cortex ulmi pumilae 100 weight portions, Radix Platycodonis 100 weight portions, Folium Mori 100 weight portions, Flos Chrysanthemi 100 weight portions, the water logging that adds 12 times of volumes of medical material gross weight in certain herbaceous plants with big flowers 100 weight portions was steeped 30 minutes;
2) heating steps 1) in medical material and water, boiled 2 hours, filter, filtering residue adds the water heating of 10 times of volumes of medical material gross weight once more, boils 2 hours, filters merging filtrate;
3) will filtrate and concentrate, preparation proportion is the mastic of 1.5 g/cm3;
4) with mastic vacuum decompression crushed after being dried, cross 120 mesh sieves, make the medicated powder powder;
5) get powder 100 weight portions that step 4) makes, carboxymethyl starch sodium 1 weight portion, sucrose 50 weight portions, hydroxyl isomaltulose 100 weight portions behind the mix homogeneously, add 95% ethanol, 15 weight portions and granulate drying, granulate;
6) take by weighing Mentholum 3 weight portions and be dissolved in the intermediate products that spray in the small amount of ethanol behind the granulate, after other added Pulvis Talci 3 weight portions, tabletting promptly got.
7. according to the buccal tablet described in claim 1 or 2, preparation promote the puerpera to subside a swelling puerperal and the medicine of stimulating milk secretion in application.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012102591882A CN102793736A (en) | 2012-07-25 | 2012-07-25 | Buccal tablet with removing throat heat and promoting diuresis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012102591882A CN102793736A (en) | 2012-07-25 | 2012-07-25 | Buccal tablet with removing throat heat and promoting diuresis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102793736A true CN102793736A (en) | 2012-11-28 |
Family
ID=47193205
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012102591882A Pending CN102793736A (en) | 2012-07-25 | 2012-07-25 | Buccal tablet with removing throat heat and promoting diuresis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102793736A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105125662A (en) * | 2015-09-07 | 2015-12-09 | 广州国宇医药科技有限公司 | Sugar alcohol composition |
| CN105581286A (en) * | 2015-12-16 | 2016-05-18 | 李新福 | Chewable tablets capable of promoting postnatal recovery of lying-in women and preparation method of chewable tablets |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1401338A (en) * | 2001-08-13 | 2003-03-12 | 姜良铎 | Buccal tablet with pharynx purging and intestine lubricating action |
-
2012
- 2012-07-25 CN CN2012102591882A patent/CN102793736A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1401338A (en) * | 2001-08-13 | 2003-03-12 | 姜良铎 | Buccal tablet with pharynx purging and intestine lubricating action |
Non-Patent Citations (1)
| Title |
|---|
| 邢锐等: "紫苏梗临床应用举隅", 《实用医药杂志》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105125662A (en) * | 2015-09-07 | 2015-12-09 | 广州国宇医药科技有限公司 | Sugar alcohol composition |
| CN105581286A (en) * | 2015-12-16 | 2016-05-18 | 李新福 | Chewable tablets capable of promoting postnatal recovery of lying-in women and preparation method of chewable tablets |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102205107B (en) | Chinese medicinal preparation for treating duodenal ulcer and preparation method thereof | |
| US20110104290A1 (en) | Compositions for reducing blood glucose level and uses thereof | |
| KR101600751B1 (en) | Method of preparing oriental medicine composition containing extract of deer antlers for treating infertility in women | |
| CN105148106A (en) | Drug for treating phthisis and preparation method of drug | |
| CN114377105A (en) | Baoyuan effervescent tablet and preparation method and application thereof | |
| CN106994141B (en) | Traditional Chinese medicine composition for treating constipation and preparation method thereof | |
| CN102793736A (en) | Buccal tablet with removing throat heat and promoting diuresis | |
| CN103356802B (en) | Medicament for treating mastitis, and preparation method thereof | |
| CN107582717B (en) | A kind of traditional Chinese medicine composition for senile constipation, preparation and preparation method thereof | |
| CN106561954A (en) | Tablet candy capable of clearing and nourishing throat and preparation method thereof | |
| CN104305193A (en) | Food having effect of promoting intestine propulsion and preparation method of food | |
| CN103405634A (en) | Changrun tea with defecation function | |
| CN105535587A (en) | Traditional Chinese medicinal preparation for treating heart and kidney disharmony type palpitation and insomnia and preparation method of traditional Chinese medicinal preparation | |
| CN1907374A (en) | Chinese medicinal composition for treating oral disease | |
| CN102793799B (en) | Buccal tablets with weight reduction effect | |
| CN104547494A (en) | Traditional Chinese medicine composition medicinal liquor for treating hyperthyroidism and preparation process | |
| CN103330861B (en) | Medicine for curing cholera and preparation method thereof | |
| CN105250563A (en) | Chinese herb preparation for treating pediatric intestinal parasites and preparing method thereof | |
| CN118902098A (en) | Composition, and preparation method and application thereof | |
| CN106266487A (en) | A kind of Chinese medicine composition treating diabetes and preparation method thereof | |
| CN106511812A (en) | Medicine for treating common cold and preparation method of medicine | |
| CN108066437B (en) | A Chinese medicinal composition and its preparation method | |
| CN102028763B (en) | Chinese patent medicine for treating cold and preparation method thereof | |
| CN105327100A (en) | Traditional Chinese medicine composition and preparation for treating chronic pharyngitis as well as preparation method thereof | |
| CN105560694A (en) | Medicine composition for treating diabetic nephropathy and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20121128 |

